PharmacovigilanceOfficial

EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation

🇪🇺 EMA · Fri 20 Nov 2026

The EU's single assessment of periodic safety reports for ibuprofen, ibuprofen lysine and ibuprofen/caffeine has ended in a regulatory outcome of variation, with documents now online.

The European Medicines Agency has published the outcome of periodic safety update report single assessment PSUSA/00010649/202602, covering ibuprofen, ibuprofen lysine and the fixed combination of ibuprofen and caffeine. The documents went online on 20 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: EMA ↗

Article written by VigiEye from the official source (EMA). AI-assisted; check the source before acting.